Tiglutik Kit — Medical Mutual
Amyotrophic Lateral Sclerosis (ALS)
Preferred products
- generic riluzole oral tablets
Initial criteria
- Patient is age ≥ 18 years; AND
- Baseline ALS Functional Rating Scale-Revised (ALSFRS-R) score measured; AND
- Patient has normal respiratory function (defined as percent-predicted forced vital capacity values ≥ 60%); AND
- Prescribed by or in consultation with a neurologist or physician who specializes in the treatment of ALS; AND
- Patient must have previously tried therapy with generic riluzole oral tablets
Reauthorization criteria
- Patient is age ≥ 18 years; AND
- Baseline ALS Functional Rating Scale-Revised (ALSFRS-R) score measured; AND
- Prescribed by or in consultation with a neurologist or physician who specializes in the treatment of ALS; AND
- Patient must have previously tried therapy with generic riluzole oral tablets
Approval duration
initial 6 months; reauth 1 year